Twist Bioscience (TWST) Current Leases (2019 - 2026)

Twist Bioscience (TWST) has 8 years of Current Leases data on file, last reported at $10.4 million in Q1 2026.

• Current Leases for Q1 2026 came in at $10.4 million, down 31.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 31.38% YoY), and the FY2025 annual result was $13.8 million, down 6.64% from the prior year.
• Current Leases declined to $10.4 million in Q1 2026 per TWST's latest filing, from $12.2 million in the prior quarter.
• Over five years, Current Leases peaked at $15.5 million in Q2 2025 and troughed at $10.4 million in Q1 2026.
• A 5-year average of $14.1 million and a median of $14.4 million in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2022 and 2026: Current Leases jumped 117.47% in 2022, then plunged 31.38% in 2026.
• A 5-year view of Current Leases shows it stood at $14.2 million in 2022, then grew by 4.08% to $14.8 million in 2023, then advanced by 1.5% to $15.0 million in 2024, then slipped by 18.55% to $12.2 million in 2025, then dropped by 14.7% to $10.4 million in 2026.
• Business Quant data shows TWST's Current Leases at $10.4 million in Q1 2026, $12.2 million in Q4 2025, and $13.8 million in Q3 2025.